⌘K
Loading ticker…
As of 2026-08-24, Vir Biotechnology, Inc. Common Stock (VIR) has a 3-month relative strength percentile of 63 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 66. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.8%, relative volume 1.19×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
VIR is in a stage 2 uptrend, week 1. Currently in a 87-day base; basing ADR 4.8% (broad 6.1%). VCP detected: 4 contractions. RS line below base-start high. Distance from 50d / 200d: 5.4% / 19.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
VIR is held by 30 ETFs as of May 2026. Top owner: SCHA at 0.02% weight, $5M notional. Top 3 carry $13M.
Held by 72 ETFs · $279M across latest filings · largest weight 1.13% (BBC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $5M | — |
| VTWO | 0.03% | $5M | — |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.06% | $4M | — |
| VHTVanguard Health Care ETF | 0.02% | $3M | — |
| AVSC | 0.10% | $3M | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.07% | $1M | — |
| PSCH | 0.57% | $754K | +0.06 pp |
| VFMO | 0.04% | $754K | new |
| VTWV | 0.06% | $700K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $652K | — |
Showing 10 of 30 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VIR Jan avg: 18.82% median: 20.07% win: 75% σ: 19.94% n: 4 2022-04-12 → 2026-07-31 | VIR Feb avg: -0.10% median: 0.12% win: 50% σ: 24.29% n: 4 2022-04-12 → 2026-07-31 | VIR Mar avg: -8.00% median: -5.65% win: 25% σ: 11.04% n: 4 2022-04-12 → 2026-07-31 | VIR Apr avg: -1.28% median: -5.56% win: 40% σ: 12.22% n: 5 2022-04-12 → 2026-07-31 | VIR May avg: 5.68% median: 6.04% win: 60% σ: 19.16% n: 5 2022-04-12 → 2026-07-31 | VIR Jun avg: -2.77% median: -1.32% win: 40% σ: 8.00% n: 5 2022-04-12 → 2026-07-31 | VIR Jul avg: -6.73% median: 0.60% win: 60% σ: 22.91% n: 5 2022-04-12 → 2026-07-31 | VIR Aug avg: -11.49% median: -12.34% win: 0% σ: 6.91% n: 4 2022-04-12 → 2026-07-31 (current) | VIR Sep avg: -9.64% median: -14.07% win: 25% σ: 18.15% n: 4 2022-04-12 → 2026-07-31 | VIR Oct avg: 0.75% median: 2.19% win: 50% σ: 12.24% n: 4 2022-04-12 → 2026-07-31 | VIR Nov avg: 15.51% median: 13.69% win: 100% σ: 10.47% n: 4 2022-04-12 → 2026-07-31 | VIR Dec avg: -4.54% median: -6.93% win: 25% σ: 7.25% n: 4 2022-04-12 → 2026-07-31 |